All Articles

LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62–Keap1–Nrf2 pathway

Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy

A systematic review and network meta analysis of first-line immunotherapy for advanced urothelial carcinoma

Fenretinide in cancer therapy and chemoprevention: past, present and future

Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer

TRAP1 ablation improves mitochondrial cristae and oxidative phosphorylation in pancreatic cancer stem cells

Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy

Novel N-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance

Paired single cell analysis reveals chemotherapy resistance in osteosarcoma

Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications

Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance

Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies

Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance

Immunotherapy resistance and strategies in malignant pleural mesothelioma

Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption

From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms